Table 2.
r | p | |
---|---|---|
Tensin2 | ||
Glut4 | 0.537 | 0.001* |
IRS-1 | 0.335 | 0.043* |
Ki-67 | 0.432 | 0.012* |
CD31 | 0.435 | 0.011* |
E-cadherin | 0.289 | 0.102 |
N-cadherin | 0.452 | 0.008* |
Fibronectin | - 0.361 | 0.039* |
Caspase3 | - 0.083 | 0.644 |
pAkt (nuclei) | 0.297 | 0.093 |
pAkt (cytoplasm) | - 0.029 | 0.872 |
pErk (nuclei) | 0.182 | 0.319 |
pErk (cytoplasm) | 0.229 | 0.200 |
Axl | ||
Glut4 | 0.247 | 0.165 |
IRS-1 | 0.133 | 0.461 |
Ki-67 | 0.119 | 0.509 |
CD31 | 0.251 | 0.159 |
E-cadherin | 0.072 | 0.690 |
N-cadherin | - 0.168 | 0.350 |
Fibronectin | - 0.345 | 0.049* |
Caspase3 | 0.149 | 0.408 |
pAkt (nuclei) | 0.058 | 0.746 |
pAkt (cytoplasm) | 0.217 | 0.224 |
pErk (nuclei) | 0.186 | 0.307 |
pErk (cytoplasm) | 0.033 | 0.856 |
The correlations were evaluated using the Pearson correlation test
Glut4 and IRS1 are involved in glycolysis; Ki-67, proliferation marker; CD31, angiogenesis marker; E-cadherin, epithelial marker; N-cadherin and fibronectin, mesenchymal marker; Caspase 3, apoptosis marker. Patient number = 33, *p < 0.05